Drug Topics Hospital Pharmacists' Report

July 26, 2012

Web Version  |   Unsubscribe  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Fertility drug use and breast cancer risk

The Two Sister Study, funded in part by Susan Komen for the Cure, was conducted to examine the possible risks associated with fertility drugs and breast cancer. The results were published July 6 in the Journal of The National Cancer Institute. » More

Continuing Education

Cultural competency

Pharmacists need to gain insight into cultural competency to better serve the increasing racial and ethnic populations in the United States.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

Omega-6 fatty acids may help prevent CHD

A new study has found that omega-6 poly-unsaturated fatty acids can help prevent coronary heart disease (CHD) and that dietary saturated fat increases the risk for CHD. » More

Strategies to combat online counterfeit drug supply

The National Association of Boards of Pharmacy issued a report last week that called for international collaboration among regulators and other public agencies to help combat the ongoing problem of the online counterfeit drug supply. » More

Carfilzomib approved for multiple myeloma treatment

FDA has approved carfilzomib (Kyprolis, Onyx Pharmaceuticals) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib (Velcade, Takeda) and an immunomodulatory therapy. » More

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out, too

Hospital pharmacists succeed in counseling

Heart failure treatments

Genomic testing for warfarin therapy

Ondansetron and link to heart rhythms

Voices

Anticoagulation Update

JP at Large: Pharmacy's crisis point

View from the Zoo: Stand up and make yourself heard

Viewpoints: Guest columnists’ commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group